Global Orexin Receptor Antagonists Market Research Report 2024(Status and Outlook)

Global Orexin Receptor Antagonists Market Research Report 2024(Status and Outlook)



Report Overview:

Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.

The Global Orexin Receptor Antagonists Market Size was estimated at USD 4811.10 million in 2023 and is projected to reach USD 6902.26 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.

This report provides a deep insight into the global Orexin Receptor Antagonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orexin Receptor Antagonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orexin Receptor Antagonists market in any manner.

Global Orexin Receptor Antagonists Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eisai Co., Ltd

Sun Pharmaceutical Industries Ltd

Novartis AG

Endo Pharmaceuticals plc

Mylan NV

Cereve Inc.

Teva Pharmaceutical Industries Ltd

Amneal Pharmaceuticals Inc

Merck & Co.

Sanofi

Currax Pharmaceuticals LLC

Pfizer Inc.

Market Segmentation (by Type)

Oral

Parenteral

Market Segmentation (by Application)

Insomnia

Anxious

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Orexin Receptor Antagonists Market

Overview of the regional outlook of the Orexin Receptor Antagonists Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orexin Receptor Antagonists Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orexin Receptor Antagonists
1.2 Key Market Segments
1.2.1 Orexin Receptor Antagonists Segment by Type
1.2.2 Orexin Receptor Antagonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Orexin Receptor Antagonists Market Overview
2.1 Global Market Overview
2.1.1 Global Orexin Receptor Antagonists Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Orexin Receptor Antagonists Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Orexin Receptor Antagonists Market Competitive Landscape
3.1 Global Orexin Receptor Antagonists Sales by Manufacturers (2019-2024)
3.2 Global Orexin Receptor Antagonists Revenue Market Share by Manufacturers (2019-2024)
3.3 Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orexin Receptor Antagonists Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orexin Receptor Antagonists Sales Sites, Area Served, Product Type
3.6 Orexin Receptor Antagonists Market Competitive Situation and Trends
3.6.1 Orexin Receptor Antagonists Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orexin Receptor Antagonists Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Orexin Receptor Antagonists Industry Chain Analysis
4.1 Orexin Receptor Antagonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Orexin Receptor Antagonists Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Orexin Receptor Antagonists Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orexin Receptor Antagonists Sales Market Share by Type (2019-2024)
6.3 Global Orexin Receptor Antagonists Market Size Market Share by Type (2019-2024)
6.4 Global Orexin Receptor Antagonists Price by Type (2019-2024)
7 Orexin Receptor Antagonists Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orexin Receptor Antagonists Market Sales by Application (2019-2024)
7.3 Global Orexin Receptor Antagonists Market Size (M USD) by Application (2019-2024)
7.4 Global Orexin Receptor Antagonists Sales Growth Rate by Application (2019-2024)
8 Orexin Receptor Antagonists Market Segmentation by Region
8.1 Global Orexin Receptor Antagonists Sales by Region
8.1.1 Global Orexin Receptor Antagonists Sales by Region
8.1.2 Global Orexin Receptor Antagonists Sales Market Share by Region
8.2 North America
8.2.1 North America Orexin Receptor Antagonists Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orexin Receptor Antagonists Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orexin Receptor Antagonists Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orexin Receptor Antagonists Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orexin Receptor Antagonists Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eisai Co., Ltd
9.1.1 Eisai Co., Ltd Orexin Receptor Antagonists Basic Information
9.1.2 Eisai Co., Ltd Orexin Receptor Antagonists Product Overview
9.1.3 Eisai Co., Ltd Orexin Receptor Antagonists Product Market Performance
9.1.4 Eisai Co., Ltd Business Overview
9.1.5 Eisai Co., Ltd Orexin Receptor Antagonists SWOT Analysis
9.1.6 Eisai Co., Ltd Recent Developments
9.2 Sun Pharmaceutical Industries Ltd
9.2.1 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
9.2.2 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
9.2.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Market Performance
9.2.4 Sun Pharmaceutical Industries Ltd Business Overview
9.2.5 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists SWOT Analysis
9.2.6 Sun Pharmaceutical Industries Ltd Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Orexin Receptor Antagonists Basic Information
9.3.2 Novartis AG Orexin Receptor Antagonists Product Overview
9.3.3 Novartis AG Orexin Receptor Antagonists Product Market Performance
9.3.4 Novartis AG Orexin Receptor Antagonists SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Endo Pharmaceuticals plc
9.4.1 Endo Pharmaceuticals plc Orexin Receptor Antagonists Basic Information
9.4.2 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Overview
9.4.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Market Performance
9.4.4 Endo Pharmaceuticals plc Business Overview
9.4.5 Endo Pharmaceuticals plc Recent Developments
9.5 Mylan NV
9.5.1 Mylan NV Orexin Receptor Antagonists Basic Information
9.5.2 Mylan NV Orexin Receptor Antagonists Product Overview
9.5.3 Mylan NV Orexin Receptor Antagonists Product Market Performance
9.5.4 Mylan NV Business Overview
9.5.5 Mylan NV Recent Developments
9.6 Cereve Inc.
9.6.1 Cereve Inc. Orexin Receptor Antagonists Basic Information
9.6.2 Cereve Inc. Orexin Receptor Antagonists Product Overview
9.6.3 Cereve Inc. Orexin Receptor Antagonists Product Market Performance
9.6.4 Cereve Inc. Business Overview
9.6.5 Cereve Inc. Recent Developments
9.7 Teva Pharmaceutical Industries Ltd
9.7.1 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Basic Information
9.7.2 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Overview
9.7.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Market Performance
9.7.4 Teva Pharmaceutical Industries Ltd Business Overview
9.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
9.8 Amneal Pharmaceuticals Inc
9.8.1 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Basic Information
9.8.2 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Overview
9.8.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Market Performance
9.8.4 Amneal Pharmaceuticals Inc Business Overview
9.8.5 Amneal Pharmaceuticals Inc Recent Developments
9.9 Merck and Co.
9.9.1 Merck and Co. Orexin Receptor Antagonists Basic Information
9.9.2 Merck and Co. Orexin Receptor Antagonists Product Overview
9.9.3 Merck and Co. Orexin Receptor Antagonists Product Market Performance
9.9.4 Merck and Co. Business Overview
9.9.5 Merck and Co. Recent Developments
9.10 Sanofi
9.10.1 Sanofi Orexin Receptor Antagonists Basic Information
9.10.2 Sanofi Orexin Receptor Antagonists Product Overview
9.10.3 Sanofi Orexin Receptor Antagonists Product Market Performance
9.10.4 Sanofi Business Overview
9.10.5 Sanofi Recent Developments
9.11 Currax Pharmaceuticals LLC
9.11.1 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Basic Information
9.11.2 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Overview
9.11.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Market Performance
9.11.4 Currax Pharmaceuticals LLC Business Overview
9.11.5 Currax Pharmaceuticals LLC Recent Developments
9.12 Pfizer Inc.
9.12.1 Pfizer Inc. Orexin Receptor Antagonists Basic Information
9.12.2 Pfizer Inc. Orexin Receptor Antagonists Product Overview
9.12.3 Pfizer Inc. Orexin Receptor Antagonists Product Market Performance
9.12.4 Pfizer Inc. Business Overview
9.12.5 Pfizer Inc. Recent Developments
10 Orexin Receptor Antagonists Market Forecast by Region
10.1 Global Orexin Receptor Antagonists Market Size Forecast
10.2 Global Orexin Receptor Antagonists Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Orexin Receptor Antagonists Market Size Forecast by Country
10.2.3 Asia Pacific Orexin Receptor Antagonists Market Size Forecast by Region
10.2.4 South America Orexin Receptor Antagonists Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Orexin Receptor Antagonists by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Orexin Receptor Antagonists Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Orexin Receptor Antagonists by Type (2025-2030)
11.1.2 Global Orexin Receptor Antagonists Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Orexin Receptor Antagonists by Type (2025-2030)
11.2 Global Orexin Receptor Antagonists Market Forecast by Application (2025-2030)
11.2.1 Global Orexin Receptor Antagonists Sales (Kilotons) Forecast by Application
11.2.2 Global Orexin Receptor Antagonists Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings